Literature DB >> 15537726

Serum transferrin receptor levels in beta-thalassemia trait.

Aysin Demir1, Nese Yarali, Tunc Fisgin, Feride Duru, Abdurrahman Kara.   

Abstract

Increased levels of transferrin receptors (TfR) and soluble TfR (sTfR) are reliable indicators of iron deficiency anemia and conditions with enhanced erythropoietic activity. In this study we measured sTfR levels in the cases of beta-thalassemia trait (betaTT) and IDA to see whether it would be a diagnostic tool for the differentiation of betaTT and IDA. On the other hand STfR levels could give an idea about erythropoietic activity in betaTT. Serum transferrin receptor (sTfR) levels were measured with enzyme immune assay in 37 cases with betaTT, in 26 patients with iron deficiency anemia (IDA), in 17 patients with the coexistence of betaTT with IDA, and in 21 healthy controls. Mean sTfR in betaTT (6.54 +/- 1.88) were statistically higher than in controls (5.09 +/- 0.76) and lower than in IDA (11.46 +/- 5.03) and in IDA coexistence with betaTT (14.44 +/- 5.3, p < 0.05 in each comparison). However, in 17 cases with betaTT sTfR levels showed an overlap between the patients with IDA, and in 15 cases with betaTT it also showed an overlap with controls. The finding of higher sTfR levels in betaTT compared with controls suggested that there was a degree of ineffective hematopoiesis in betaTT. Although sTfR levels in IDA were higher than in betaTT, because of largely overlapping values in both groups, it was not satisfactory to distinguish betaTT from IDA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537726     DOI: 10.1093/tropej/50.6.369

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  4 in total

1.  Executive summary--Biomarkers of Nutrition for Development: Building a Consensus.

Authors:  Daniel J Raiten; Sorrel Namasté; Bernard Brabin; Gerald Combs; Mary R L'Abbe; Emorn Wasantwisut; Ian Darnton-Hill
Journal:  Am J Clin Nutr       Date:  2011-07-06       Impact factor: 7.045

2.  Therapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia.

Authors:  Guanheng Yang; Wansheng Shi; Xingyin Hu; Jingzhi Zhang; Zhijuan Gong; Xinbing Guo; Zhaorui Ren; Fanyi Zeng
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

3.  Altered erythropoiesis and iron metabolism in carriers of thalassemia.

Authors:  Jacqueline S Guimarães; Juçara G Cominal; Ana Cristina Silva-Pinto; Gordana Olbina; Yelena Z Ginzburg; Vijay Nandi; Mark Westerman; Stefano Rivella; Ana Maria de Souza
Journal:  Eur J Haematol       Date:  2014-11-11       Impact factor: 2.997

4.  Study of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia children.

Authors:  Seham M Ragab; Manal A Safan; Eman A Badr
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-02-15       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.